DMN:FRA
Diamyd Medical AB
0,068 €
0,00%
(0,00) 1D
11 նոյ, 08:45:32 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Open
0,07 €
High
0,07 €
Low
0,07 €
Mkt. cap
145,72 մլն
Avg. vol.
0,00
Volume
0,00
52-wk high
1,80 €
52-wk low
0,05 €
No. of employees
42
Open
0,07 €
High
0,07 €
Low
0,07 €
Mkt. cap
145,72 մլն
Avg. vol.
0,00
Volume
0,00
52-wk high
1,80 €
52-wk low
0,05 €
No. of employees
42
News stories
From web sources and news partners
TradingView
·
56 րոպե առաջ
S&P 500, Nasdaq Futures Rise Premarket — CRWV, GPRO, SPCX, NVDA, NLST Stocks In Focus
FXStreet
·
54 րոպե առաջ
S&P 500: Higher yields weigh on equities – Deutsche Bank
Reuters
·
11 րոպե առաջ
S&P 500, Nasdaq futures rise after CoreWeave soothes AI spending fears
The Motley Fool
·
44 րոպե առաջ
Why the S&P 500 Could Be Heading for a Repeat of 2018
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB